OVERVIEW
Patients with [italic]H.pylori[/italic] infection are typically treated empirically with proton pump inhibitors (PPIs) and antibiotics. However, this may not be sufficient to cure the infection, placing patients at risk for serious consequences such as gastritis, ulcers, and gastric cancer. Standard first-line therapy is often inadequate due to antibiotic resistance and failure of clinicians to ask about prior antibiotic use. In this live CME event, 3 experts will discuss the epidemiology, consequences of under treatment, and updated guidance on treatment strategies for [italic]H.pylori[/italic] infection. They will present the latest evidence for the efficacy of different treatment approaches as well as emerging clinical data on a novel class of treatment, P-CABS, with a new mechanism of action that is in late-stage development for [italic]H.pylori[/italic] infection.
GOAL STATEMENT
The goal of this activity is to improve the evidence-based management of [italic]H.pylori [/italic] infection.
LEARNING OBJECTIVES
Upon completion of this activity, participants will: Have increased knowledge regarding the [LIST] [ITEM]Consequences of untreated or persistent [italic]H.pylori[/italic] infection [ITEM]Mechanism of treatment targets in the context of [italic]H.pylori[/italic] pathology [ITEM]Clinical data on emerging treatments [italic]H.pylori[/italic] infection[/LIST] Demonstrate greater confidence in their ability to [LIST] [ITEM]Implement evidence-based [italic]H.pylori[/italic] treatments [LIST]
ACCREDITATION STATEMENT
In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. [JALOGO] [MEDSCAPE]
Medscape, LLC designates this live activity for a maximum of 1.0 [italic]AMA PRA Category 1 Credits™[/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Mandalay Bay Resort & Casino
3950 South Las Vegas Boulevard South Oceanside Ballroom Section C
Las Vegas, Nevada, 89119
United States
This event is neither sponsored by nor endorsed by ACG.
Supported by an independent educational grant from [bold]Phathom Pharmaceuticals[bold].